Biosidus Revenue and Competitors
Estimated Revenue & Valuation
- Biosidus's estimated annual revenue is currently $117.4M per year.
- Biosidus's estimated revenue per employee is $201,000
Employee Data
- Biosidus has 584 Employees.
- Biosidus grew their employee count by 14% last year.
Biosidus's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Africa, Middle East & Euroasia | Reveal Email/Phone |
Biosidus Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Biosidus?
Biosidus es una compañÃa de biotecnologÃa argentina que en las últimas dos décadas ha desarrollado un negocio global de investigación, desarrollo, producción y comercialización de biofármacos de alta calidad en territorios de Asia, Ãfrica, Europa del Este y América Latina. Biosidus cuenta con dos Plantas Industriales y un Laboratorio de Investigación y Desarrollo. La Planta Almagro, ubicada en la Ciudad Autónoma de Buenos Aires, está dedicada a actividades de I+D y a la producción de principios activos farmacéuticos, con capacidad productiva en fermentación bacteriana y cultivo celular masivo. Las operaciones de llenado aséptico, liofilización y empaque se llevan a cabo en la Planta Bernal, ubicada en dicha localidad de la Provincia de Buenos Aires.
keywords:N/A
N/A
Total Funding
584
Number of Employees
$117.4M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biosidus News
Roche; Biosidus; Nanogen; Amega Biotech; Zydus Cadila; 3sbio; Rhein Minapharm Biogenetics; PROBIOMED. Interferon Alpha-2a Biosimilar Market Breakdown by Type...
Roche; Biosidus; Zydus Cadila; Nanogen; Amega Biotech; Rhein Minapharm Biogenetics; PROBIOMED; 3Sbio. Interferon Sales Market Breakdown by Type:.
Biosidus; Zydus Cadila; Nanogen; Amega Biotech; Rhein Minapharm Biogenetics; PROBIOMED; 3sbio; Amgen; Bayer; Schering Plough; Merck. Interferon Biosimilar...